Literature DB >> 9012901

Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery.

H Tanigami1, N Yahagi, K Kumon, Y Watanabe, M Haruna, J Matsui, H Hayashi.   

Abstract

After cardiac surgery, patients often require prolonged mechanical ventilation. We studied the effectiveness and potential toxicity of isoflurane sedation in 40 patients undergoing mechanical ventilation after cardiovascular surgery. All patients who received isoflurane (0.5-1.0 minimum alveolar concentration [MAC] were well sedated by it without significant adverse effects, such as renal, hepatic, or cardiovascular dysfunction. The highest serum inorganic fluoride concentration recorded was 45 mumol/L after 98 MAC h. Patients on isoflurane recovered more rapidly and were weaned from mechanical ventilation sooner than those sedated with intravenous drugs including fentanyl/midazolam. Patients who received intravenous sedatives, but not those on isoflurane, often showed tachyphylaxis in the early stages, and some exhibited an abstinence syndrome involving nonpurposeful movements. Patients sedated with isoflurane did not show these two side effects. In conclusion, isoflurane can provide effective long-term sedation for patients after cardiovascular surgery without significant adverse effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012901     DOI: 10.1111/j.1525-1594.1997.tb00693.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  7 in total

1.  [Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system].

Authors:  J Kompardt; K Schärff; K Kubosch; C Pohl; M Bomplitz; J Soukup
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

Review 2.  Toxicity of inhaled agents after prolonged administration.

Authors:  Panumart Manatpon; W Andrew Kofke
Journal:  J Clin Monit Comput       Date:  2017-11-02       Impact factor: 2.502

3.  Isoflurane for life-threatening bronchospasm: a 15-year single-center experience.

Authors:  David A Turner; David Heitz; Mehrengise K Cooper; P Brian Smith; John H Arnold; Scot T Bateman
Journal:  Respir Care       Date:  2012-03-13       Impact factor: 2.258

4.  Longitudinal impact on rat cardiac tissue transcriptomic profiles due to acute intratracheal inhalation exposures to isoflurane.

Authors:  Sung-Hyun Park; Yuting Lu; Yongzhao Shao; Colette Prophete; Lori Horton; Maureen Sisco; Hyun-Wook Lee; Thomas Kluz; Hong Sun; Max Costa; Judith Zelikoff; Lung-Chi Chen; Mitchell D Cohen
Journal:  PLoS One       Date:  2021-10-14       Impact factor: 3.752

5.  Heat and moisture exchanger used in a cardiothoracic surgery intensive care unit: Airway resistance and changing interval.

Authors:  Huan Liu; Hongpeng Wang; Zeshu Mu; Lin Ye; Yingjiu Jiang
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-10-21       Impact factor: 0.332

6.  Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive care patients: study protocol for a randomized controlled trial.

Authors:  Jens Soukup; Antje Selle; Andreas Wienke; Jörg Steighardt; Nana-Maria Wagner; Patrick Kellner
Journal:  Trials       Date:  2012-08-10       Impact factor: 2.279

Review 7.  The role of systematic reviews in pharmacovigilance planning and Clinical Trials Authorisation application: example from the SLEEPS trial.

Authors:  Carrol Gamble; Andrew Wolf; Ian Sinha; Catherine Spowart; Paula Williamson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.